Diet and supplementation and the incidence of depression and sexual satisfaction in woman taking combined oral contraceptive pill
Abstract
INTRODUCTION: The aim of the following publication is to elucidate the links between lifestyle, diet and the incidence of depression and the level of sexual satisfaction in women using combined oral contraceptive pill (COCP)
MATERIAL AND METHODS: The study was done using questionnaires. There were 105 participants, all women 18 to 47 years old COCP. The methods used included: Health Behaviors Inventory (Juczyński 1999), Sexual Sastisfaction Questionnaire (Nomejko, Dolińska-Zygmunt 2014) and Kwestionariusz do Pomiaru Depresji (Depression Assessment Questionnaire) (KPD; Łojek E. et al. 2015), as well as a separate questionnaire regarding basic information about the participants.
RESULTS AND CONCLUSIONS: The study found that 31% of the participants had highly intensive features of depression and 10% met the point threshold for the diagnosis of depression in KPD scale. The results also show that the participants who used omega-3 fatty acid supplementation experience fewer psychosomatic symptoms of depression (including loss of interest in life activities), compared to participants not using the supplementation. There was also low and moderate correlation between the level of sexual satisfaction and the occurrence of depressive symptoms (negative correlation), as well as between the occurrence of depressive symptoms and proper dietary habits and healthy lifestyle ( negative correlation). In addition, there was a negative correlation between proper dietary habits and cognitive deficit as well as loss of stamina which were the signs of depression.
Keywords: dietsupplementationcontraceptionCOCPdepressionsexual satisfactionhealth behaviours
References
- Skałba P. Endokrynologia ginekologiczna. Wydawnictwo Lekarskie PZWL, Warszawa 1998.
- Bręborowicz GH. Położnictwo i ginekologia. Wydawnictwo Lekarskie PZWL, Warszawa 2005.
- Meisenbacher K. Antykoncepcja. MedPharm Polska, Wrocław, Wrocław 2008.
- Rosenhan DL, Seligman MEP, Walker EF. Psychopatologia. Wydawnictwo Zysk i S-ka, Poznań. 2003.
- Bilikiewicz A. Psychiatria. Podręcznik dla studentów medycyny. Wydawnictwo Lekarskie PZWL, Warszawa 2009.
- Łojek E, Stańczak J, Wójcik A. Kwestionariusz do pomiaru depresji. Podręcznik. Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, Warszawa 2015.
- Nomejko A, Dolińska-Zygmunt G. The Sexual Satisfaction Questionnaire – psychometric properties. Polish Journal of Applied Psychology. 2014(3): 105–112.
- Gahr M, Freudenmann RW, Connemann BJ, et al. Rapid relapse in depression following initialization of oral contraception with ethinyl estradiol and chlormadinone acetate. Gen Hosp Psychiatry. 2014; 36(2): 230–235.
- Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opin Drug Saf. 2007; 6(4): 371–374.
- Cheslack-Postava K, Keyes KM, Lowe SR, et al. Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Arch Womens Ment Health. 2015; 18(1): 103–111.
- Davis AR, Castaño PM. Oral contraceptives and libido in women. Ann Rev Sex Res. 2004; 15: 297–320.
- Wallwiener CW, Wallwiener LM, Seeger H, et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010; 7(6): 2139–2148.
- Peet M. Nutrition and depression. Northern Centre for Mental Health 2004; 5. 2004; 5: 145–156.
- Westover AN, Marangell LB. A cross-national relationship between sugar consumption and major depression? Depress Anxiety. 2002; 16(3): 118–120.
- Harbottle L. Nutrition and mental health: the importance of diet in depression. British Journal of Wellbeing. 2011; 2(7): 19–22.
- Shaw K, Turner J, Del Ma. Tryptophan and 5-Hydroxytryptophan for depression. The Cochrane Library. John Wiley and Sons, Chichester 2004.
- Taylor M.J. Taylor M.J., Carney S., Geddes J., Goodwin G. Folate for depressive disorders. The Cochrane Library. John Wiley and Sons, Chichester 2004.
- Lopresti AL, Maes M, Maker GL, et al. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord. 2014; 167: 368–375.
- Hoang MT, Defina LF, Willis BL, et al. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc. 2011; 86(11): 1050–1055.
- Jorde R, Sneve M, Figenschau Y, et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008; 264(6): 599–609.
- Mössner R, Mikova O, Koutsilieri E, et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry. 2007; 8(3): 141–174.
- Krawczyk K, Rybakowski J. Zastosowania kwasów omega-3 w leczeniu depresji. Farmakoterapia w Psychiatrii i Neurologii . 2007; 2: 101–107.
- Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003; 13(4): 267–271.
- Rogers PJ, Appleton KM, Kessler D, et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr. 2008; 99(2): 421–431.
- Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2012; 17(12): 1272–1282.
- Wilczyńska A. Kwasy tłuszczowe w leczeniu w zapobieganiu depresji. Psychiatria Polska . 2013; 4: 657–666.
- Juczyński Z. Narzędzia pomiaru w psychologii zdrowia. Pracownia Testów Psychologicznych PTP, Warszawa 2009.
- Jarosz M, Pachocka L. Praktyczny podręcznik dietetyki. Instytut Żywności i Żywienia, Warszawa 2010.
- Gałecki P, Gałecki P, Gałecki P, et al. Teoria zapalna depresji — podstawowe fakty. Psychiatria . 2012; 2: 68–75.
